blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3607069

EP3607069 - PRODUCTS AND COMPOSITIONS [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  30.09.2022
Database last updated on 25.09.2024
FormerGrant of patent is intended
Status updated on  31.05.2022
FormerExamination is in progress
Status updated on  11.09.2020
FormerRequest for examination was made
Status updated on  10.01.2020
FormerThe international publication has been made
Status updated on  13.10.2018
Formerunknown
Status updated on  19.04.2018
Most recent event   Tooltip27.06.2024Change - lapse in a contracting state
State(s) deleted from list of lapses: AL		published on 31.07.2024  [2024/31]
Applicant(s)For all designated states
Silence Therapeutics GmbH
Robert-Rössle-Strasse 10
13125 Berlin / DE
[2022/44]
Former [2020/07]For all designated states
Silence Therapeutics GmbH
Robert-Rössle-Strasse 10
13125 Berlin / DE
Inventor(s)01 / HAUPTMANN, Judith
c/o Silence Therapeutics GmbH
Robert-Rössle-Strasse 10
13125 Berlin / DE
02 / SAMARSKY, Dmitry
c/o Silence Therapeutics GmbH
Robert-Rössle-Strasse 10
13125 Berlin / DE
03 / FRAUENDORF, Christian
Zimbelstr. 67
13127 Berlin / DE
 [2020/09]
Former [2020/07]01 / HAUPTMANN, Judith
c/o Silence Therapeutics GmbH
Robert-Rössle-Strasse 10
13125 Berlin / DE
02 / SAMARSKY, Dmitry
c/o Silence Therapeutics GmbH
Robert-Rössle-Strasse 10
13125 Berlin / DE
03 / FRAUENDORF, Christian
Robert-Rössle-Strasse 10
13125 Berlin / DE
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[2022/44]
Former [2020/07]CMS Cameron McKenna Nabarro Olswang LLP
Cannon Place
78 Cannon Street
London EC4N 6AF / GB
Application number, filing date18715706.005.04.2018
[2020/07]
WO2018EP58766
Priority number, dateEP2017016512905.04.2017         Original published format: EP 17165129
GB2017000720305.05.2017         Original published format: GB 201707203
GB2017000839725.05.2017         Original published format: GB 201708397
EP2017020135213.11.2017         Original published format: EP 17201352
[2020/07]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018185241
Date:11.10.2018
Language:EN
[2018/41]
Type: A1 Application with search report 
No.:EP3607069
Date:12.02.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 11.10.2018 takes the place of the publication of the European patent application.
[2020/07]
Type: B1 Patent specification 
No.:EP3607069
Date:02.11.2022
Language:EN
[2022/44]
Search report(s)International search report - published on:EP11.10.2018
ClassificationIPC:C12N15/113, A61K31/713
[2020/07]
CPC:
C12N15/113 (EP,US); A61K31/713 (EP); A61K47/549 (EP);
C07H21/00 (EP); C07H21/02 (EP); C07H21/04 (EP);
C12N2310/14 (EP,US); C12N2310/313 (EP,US); C12N2310/315 (EP);
C12N2310/321 (EP,US); C12N2310/322 (US); C12N2310/344 (EP);
C12N2310/346 (EP); C12N2310/351 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/07]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:PRODUKTE UND ZUSAMMENSETZUNGEN[2020/07]
English:PRODUCTS AND COMPOSITIONS[2020/07]
French:PRODUITS ET COMPOSITIONS[2020/07]
Entry into regional phase05.11.2019National basic fee paid 
05.11.2019Designation fee(s) paid 
05.11.2019Examination fee paid 
Examination procedure05.11.2019Examination requested  [2020/07]
05.11.2019Date on which the examining division has become responsible
20.05.2020Amendment by applicant (claims and/or description)
15.09.2020Despatch of a communication from the examining division (Time limit: M06)
05.03.2021Reply to a communication from the examining division
10.06.2021Despatch of a communication from the examining division (Time limit: M04)
20.10.2021Reply to a communication from the examining division
01.06.2022Communication of intention to grant the patent
22.09.2022Fee for grant paid
22.09.2022Fee for publishing/printing paid
22.09.2022Receipt of the translation of the claim(s)
Divisional application(s)EP22202294.9  / EP4219713
Opposition(s)Opponent(s)01  31.07.2023  01.08.2023  ADMISSIBLE
Ammelburg, Moritz
HighLight Business Towers
Mies-van-der-Rohe-Strasse 8
80807 München / DE
Opponent's representative
Fish & Richardson P.C.
Highlight Business Towers
Mies-van-der-Rohe-Straße 8
80807 München / DE
 [N/P]
Former [2024/11]
Opponent(s)01  31.07.2023  01.08.2023  ADMISSIBLE
Ammelburg, Mortitz
HighLight Business Towers
Mies-van-der-Rohe-Strasse 8
80807 München / DE
Opponent's representative
Fish & Richardson P.C.
Highlight Business Towers
Mies-van-der-Rohe-Straße 8
80807 München / DE
Former [2023/36]
Opponent(s)01  31.07.2023  01.08.2023  ADMISSIBLE
Ammelburg, Mortitz
HighLight Business Towers
Mies-van-der-Rohe-Strasse 8
80807 München / DE
17.08.2023Invitation to proprietor to file observations on the notice of opposition
21.12.2023Reply of patent proprietor to notice(s) of opposition
Fees paidRenewal fee
05.11.2019Renewal fee patent year 03
21.04.2021Renewal fee patent year 04
21.03.2022Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipSM02.11.2022
[2024/31]
Former [2023/37]AL02.11.2022
SM02.11.2022
Former [2023/33]SM02.11.2022
Cited inInternational search[X]US2005080246  (ALLERSON CHARLES [US], et al);
 [X]WO2007112414  (ISIS PHARMACEUTICALS INC [US], et al);
 [X]WO2009002944  (ISIS PHARMACEUTICALS INC [US], et al);
 [X]WO2010078536  (RXI PHARMACEUTICALS CORP [US], et al);
 [X]WO2013074974  (ALNYLAM PHARMACEUTICALS INC [US]);
 [X]WO2013075035  (ALNYLAM PHARMACEUTICALS [US]);
 [X]WO2016085852  (ALNYLAM PHARMACEUTICALS INC [US]);
 [X]WO2016161388  (UNIV MASSACHUSETTS [US]);
 [X]WO2017030973  (UNIV MASSACHUSETTS [US]);
OppositionWO2007022369
 WO2007112414
 WO2009002944
 WO2009073809
 WO2010039548
 WO2012037254
 WO2013074974
 WO2015006740
 WO2015188194
 WO2016085852
 WO2017059223
 WO2017214112
 WO2018027106
 WO2018132432
 WO2018140920
 WO2018185241
 WO2019051402
 WO2019055633
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.